Clinical trial of Siddha medicine MV Kashayam (Internally) for the management and treatment of COVID 19 patients
- Conditions
- Health Condition 1: - Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 3: U071- COVID 19 virus identified
- Registration Number
- CTRI/2022/02/040365
- Lead Sponsor
- Harshana Herbal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Patient positive with Rt PCR test
2 The age group of 15 to 60 years
3 Patients with mild and moderate symptoms of COVID 19
4 Patients of both sexes and willing to accept the treatment method
1 RT PCR negative patients
2 Patients less than 15 years of age and above 60 years of age
3 Pregnant and breastfeeding women
4 Patients with severe COVID 19 symptoms
5 Patients with other systemic malignant diseases such as malignant tumors, mental
illness etc., which the researchers consider unsuitable for participation in the study
6 Allopathic antiviral treatment patients.
7 Not willing to continue the treatment
8. Patient discharge against medical advice
9 Patients participating in other clinical trails
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RT PCR negative and or symptomatic reduction in the patientsTimepoint: RT PCR negative and or symptomatic reduction in the patients within 14 days of first swab taken.
- Secondary Outcome Measures
Name Time Method Even after Length of stay in hospitalization following patients were consider to have poor out come even then duration of hospital stay is less. Patients referred to higher center. Patients who were dead after receiving five days of our treatment.For following patients with less duration of hospital stay are consider to have good out come were discharged and referred to COVID care center or home isolation under supervision.Timepoint: 4 to 10 days